Global Meningococcal Vaccination Market Growth 2023-2029

February 2023 | 92 pages | ID: G9BA48A77DDDEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Meningococcal Vaccination Industry Forecast” looks at past sales and reviews total world Meningococcal Vaccination sales in 2022, providing a comprehensive analysis by region and market sector of projected Meningococcal Vaccination sales for 2023 through 2029. With Meningococcal Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meningococcal Vaccination industry.

This Insight Report provides a comprehensive analysis of the global Meningococcal Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meningococcal Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Meningococcal Vaccination market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meningococcal Vaccination and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meningococcal Vaccination.

The global Meningococcal Vaccination market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Meningococcal Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Meningococcal Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Meningococcal Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Meningococcal Vaccination players cover GlaxoSmithKline, JN-International Medical, Novartis International, Sanofi, Pfizer, Baxter International, Biomed and Serum Institute of India, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Meningococcal Vaccination market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Polysaccharide
• Conjugate
• Combination

Segmentation by application

• Pneumonia
• Meningitis
• Bacteremia
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GlaxoSmithKline
• JN-International Medical
• Novartis International
• Sanofi
• Pfizer
• Baxter International
• Biomed
• Serum Institute of India

Key Questions Addressed in this Report

What is the 10-year outlook for the global Meningococcal Vaccination market?

What factors are driving Meningococcal Vaccination market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Meningococcal Vaccination market opportunities vary by end market size?

How does Meningococcal Vaccination break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Meningococcal Vaccination Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Meningococcal Vaccination by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Meningococcal Vaccination by Country/Region, 2018, 2022 & 2029
2.2 Meningococcal Vaccination Segment by Type
  2.2.1 Polysaccharide
  2.2.2 Conjugate
  2.2.3 Combination
2.3 Meningococcal Vaccination Sales by Type
  2.3.1 Global Meningococcal Vaccination Sales Market Share by Type (2018-2023)
  2.3.2 Global Meningococcal Vaccination Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Meningococcal Vaccination Sale Price by Type (2018-2023)
2.4 Meningococcal Vaccination Segment by Application
  2.4.1 Pneumonia
  2.4.2 Meningitis
  2.4.3 Bacteremia
  2.4.4 Others
2.5 Meningococcal Vaccination Sales by Application
  2.5.1 Global Meningococcal Vaccination Sale Market Share by Application (2018-2023)
  2.5.2 Global Meningococcal Vaccination Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Meningococcal Vaccination Sale Price by Application (2018-2023)

3 GLOBAL MENINGOCOCCAL VACCINATION BY COMPANY

3.1 Global Meningococcal Vaccination Breakdown Data by Company
  3.1.1 Global Meningococcal Vaccination Annual Sales by Company (2018-2023)
  3.1.2 Global Meningococcal Vaccination Sales Market Share by Company (2018-2023)
3.2 Global Meningococcal Vaccination Annual Revenue by Company (2018-2023)
  3.2.1 Global Meningococcal Vaccination Revenue by Company (2018-2023)
  3.2.2 Global Meningococcal Vaccination Revenue Market Share by Company (2018-2023)
3.3 Global Meningococcal Vaccination Sale Price by Company
3.4 Key Manufacturers Meningococcal Vaccination Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Meningococcal Vaccination Product Location Distribution
  3.4.2 Players Meningococcal Vaccination Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR MENINGOCOCCAL VACCINATION BY GEOGRAPHIC REGION

4.1 World Historic Meningococcal Vaccination Market Size by Geographic Region (2018-2023)
  4.1.1 Global Meningococcal Vaccination Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Meningococcal Vaccination Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Meningococcal Vaccination Market Size by Country/Region (2018-2023)
  4.2.1 Global Meningococcal Vaccination Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Meningococcal Vaccination Annual Revenue by Country/Region (2018-2023)
4.3 Americas Meningococcal Vaccination Sales Growth
4.4 APAC Meningococcal Vaccination Sales Growth
4.5 Europe Meningococcal Vaccination Sales Growth
4.6 Middle East & Africa Meningococcal Vaccination Sales Growth

5 AMERICAS

5.1 Americas Meningococcal Vaccination Sales by Country
  5.1.1 Americas Meningococcal Vaccination Sales by Country (2018-2023)
  5.1.2 Americas Meningococcal Vaccination Revenue by Country (2018-2023)
5.2 Americas Meningococcal Vaccination Sales by Type
5.3 Americas Meningococcal Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Meningococcal Vaccination Sales by Region
  6.1.1 APAC Meningococcal Vaccination Sales by Region (2018-2023)
  6.1.2 APAC Meningococcal Vaccination Revenue by Region (2018-2023)
6.2 APAC Meningococcal Vaccination Sales by Type
6.3 APAC Meningococcal Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Meningococcal Vaccination by Country
  7.1.1 Europe Meningococcal Vaccination Sales by Country (2018-2023)
  7.1.2 Europe Meningococcal Vaccination Revenue by Country (2018-2023)
7.2 Europe Meningococcal Vaccination Sales by Type
7.3 Europe Meningococcal Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Meningococcal Vaccination by Country
  8.1.1 Middle East & Africa Meningococcal Vaccination Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Meningococcal Vaccination Revenue by Country (2018-2023)
8.2 Middle East & Africa Meningococcal Vaccination Sales by Type
8.3 Middle East & Africa Meningococcal Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meningococcal Vaccination
10.3 Manufacturing Process Analysis of Meningococcal Vaccination
10.4 Industry Chain Structure of Meningococcal Vaccination

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Meningococcal Vaccination Distributors
11.3 Meningococcal Vaccination Customer

12 WORLD FORECAST REVIEW FOR MENINGOCOCCAL VACCINATION BY GEOGRAPHIC REGION

12.1 Global Meningococcal Vaccination Market Size Forecast by Region
  12.1.1 Global Meningococcal Vaccination Forecast by Region (2024-2029)
  12.1.2 Global Meningococcal Vaccination Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Meningococcal Vaccination Forecast by Type
12.7 Global Meningococcal Vaccination Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 GlaxoSmithKline
  13.1.1 GlaxoSmithKline Company Information
  13.1.2 GlaxoSmithKline Meningococcal Vaccination Product Portfolios and Specifications
  13.1.3 GlaxoSmithKline Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 GlaxoSmithKline Main Business Overview
  13.1.5 GlaxoSmithKline Latest Developments
13.2 JN-International Medical
  13.2.1 JN-International Medical Company Information
  13.2.2 JN-International Medical Meningococcal Vaccination Product Portfolios and Specifications
  13.2.3 JN-International Medical Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 JN-International Medical Main Business Overview
  13.2.5 JN-International Medical Latest Developments
13.3 Novartis International
  13.3.1 Novartis International Company Information
  13.3.2 Novartis International Meningococcal Vaccination Product Portfolios and Specifications
  13.3.3 Novartis International Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Novartis International Main Business Overview
  13.3.5 Novartis International Latest Developments
13.4 Sanofi
  13.4.1 Sanofi Company Information
  13.4.2 Sanofi Meningococcal Vaccination Product Portfolios and Specifications
  13.4.3 Sanofi Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Sanofi Main Business Overview
  13.4.5 Sanofi Latest Developments
13.5 Pfizer
  13.5.1 Pfizer Company Information
  13.5.2 Pfizer Meningococcal Vaccination Product Portfolios and Specifications
  13.5.3 Pfizer Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Pfizer Main Business Overview
  13.5.5 Pfizer Latest Developments
13.6 Baxter International
  13.6.1 Baxter International Company Information
  13.6.2 Baxter International Meningococcal Vaccination Product Portfolios and Specifications
  13.6.3 Baxter International Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Baxter International Main Business Overview
  13.6.5 Baxter International Latest Developments
13.7 Biomed
  13.7.1 Biomed Company Information
  13.7.2 Biomed Meningococcal Vaccination Product Portfolios and Specifications
  13.7.3 Biomed Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Biomed Main Business Overview
  13.7.5 Biomed Latest Developments
13.8 Serum Institute of India
  13.8.1 Serum Institute of India Company Information
  13.8.2 Serum Institute of India Meningococcal Vaccination Product Portfolios and Specifications
  13.8.3 Serum Institute of India Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Serum Institute of India Main Business Overview
  13.8.5 Serum Institute of India Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Meningococcal Vaccination Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Meningococcal Vaccination Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Polysaccharide
Table 4. Major Players of Conjugate
Table 5. Major Players of Combination
Table 6. Global Meningococcal Vaccination Sales by Type (2018-2023) & (K Units)
Table 7. Global Meningococcal Vaccination Sales Market Share by Type (2018-2023)
Table 8. Global Meningococcal Vaccination Revenue by Type (2018-2023) & ($ million)
Table 9. Global Meningococcal Vaccination Revenue Market Share by Type (2018-2023)
Table 10. Global Meningococcal Vaccination Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Meningococcal Vaccination Sales by Application (2018-2023) & (K Units)
Table 12. Global Meningococcal Vaccination Sales Market Share by Application (2018-2023)
Table 13. Global Meningococcal Vaccination Revenue by Application (2018-2023)
Table 14. Global Meningococcal Vaccination Revenue Market Share by Application (2018-2023)
Table 15. Global Meningococcal Vaccination Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Meningococcal Vaccination Sales by Company (2018-2023) & (K Units)
Table 17. Global Meningococcal Vaccination Sales Market Share by Company (2018-2023)
Table 18. Global Meningococcal Vaccination Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Meningococcal Vaccination Revenue Market Share by Company (2018-2023)
Table 20. Global Meningococcal Vaccination Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Meningococcal Vaccination Producing Area Distribution and Sales Area
Table 22. Players Meningococcal Vaccination Products Offered
Table 23. Meningococcal Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Meningococcal Vaccination Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Meningococcal Vaccination Sales Market Share Geographic Region (2018-2023)
Table 28. Global Meningococcal Vaccination Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Meningococcal Vaccination Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Meningococcal Vaccination Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Meningococcal Vaccination Sales Market Share by Country/Region (2018-2023)
Table 32. Global Meningococcal Vaccination Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Meningococcal Vaccination Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Meningococcal Vaccination Sales by Country (2018-2023) & (K Units)
Table 35. Americas Meningococcal Vaccination Sales Market Share by Country (2018-2023)
Table 36. Americas Meningococcal Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Meningococcal Vaccination Revenue Market Share by Country (2018-2023)
Table 38. Americas Meningococcal Vaccination Sales by Type (2018-2023) & (K Units)
Table 39. Americas Meningococcal Vaccination Sales by Application (2018-2023) & (K Units)
Table 40. APAC Meningococcal Vaccination Sales by Region (2018-2023) & (K Units)
Table 41. APAC Meningococcal Vaccination Sales Market Share by Region (2018-2023)
Table 42. APAC Meningococcal Vaccination Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Meningococcal Vaccination Revenue Market Share by Region (2018-2023)
Table 44. APAC Meningococcal Vaccination Sales by Type (2018-2023) & (K Units)
Table 45. APAC Meningococcal Vaccination Sales by Application (2018-2023) & (K Units)
Table 46. Europe Meningococcal Vaccination Sales by Country (2018-2023) & (K Units)
Table 47. Europe Meningococcal Vaccination Sales Market Share by Country (2018-2023)
Table 48. Europe Meningococcal Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Meningococcal Vaccination Revenue Market Share by Country (2018-2023)
Table 50. Europe Meningococcal Vaccination Sales by Type (2018-2023) & (K Units)
Table 51. Europe Meningococcal Vaccination Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Meningococcal Vaccination Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Meningococcal Vaccination Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Meningococcal Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Meningococcal Vaccination Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Meningococcal Vaccination Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Meningococcal Vaccination Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Meningococcal Vaccination
Table 59. Key Market Challenges & Risks of Meningococcal Vaccination
Table 60. Key Industry Trends of Meningococcal Vaccination
Table 61. Meningococcal Vaccination Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Meningococcal Vaccination Distributors List
Table 64. Meningococcal Vaccination Customer List
Table 65. Global Meningococcal Vaccination Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Meningococcal Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Meningococcal Vaccination Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Meningococcal Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Meningococcal Vaccination Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Meningococcal Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Meningococcal Vaccination Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Meningococcal Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Meningococcal Vaccination Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Meningococcal Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Meningococcal Vaccination Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Meningococcal Vaccination Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Meningococcal Vaccination Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Meningococcal Vaccination Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. GlaxoSmithKline Basic Information, Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 80. GlaxoSmithKline Meningococcal Vaccination Product Portfolios and Specifications
Table 81. GlaxoSmithKline Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. GlaxoSmithKline Main Business
Table 83. GlaxoSmithKline Latest Developments
Table 84. JN-International Medical Basic Information, Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 85. JN-International Medical Meningococcal Vaccination Product Portfolios and Specifications
Table 86. JN-International Medical Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. JN-International Medical Main Business
Table 88. JN-International Medical Latest Developments
Table 89. Novartis International Basic Information, Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 90. Novartis International Meningococcal Vaccination Product Portfolios and Specifications
Table 91. Novartis International Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Novartis International Main Business
Table 93. Novartis International Latest Developments
Table 94. Sanofi Basic Information, Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 95. Sanofi Meningococcal Vaccination Product Portfolios and Specifications
Table 96. Sanofi Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Sanofi Main Business
Table 98. Sanofi Latest Developments
Table 99. Pfizer Basic Information, Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 100. Pfizer Meningococcal Vaccination Product Portfolios and Specifications
Table 101. Pfizer Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Pfizer Main Business
Table 103. Pfizer Latest Developments
Table 104. Baxter International Basic Information, Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 105. Baxter International Meningococcal Vaccination Product Portfolios and Specifications
Table 106. Baxter International Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Baxter International Main Business
Table 108. Baxter International Latest Developments
Table 109. Biomed Basic Information, Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 110. Biomed Meningococcal Vaccination Product Portfolios and Specifications
Table 111. Biomed Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Biomed Main Business
Table 113. Biomed Latest Developments
Table 114. Serum Institute of India Basic Information, Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 115. Serum Institute of India Meningococcal Vaccination Product Portfolios and Specifications
Table 116. Serum Institute of India Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Serum Institute of India Main Business
Table 118. Serum Institute of India Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Meningococcal Vaccination
Figure 2. Meningococcal Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meningococcal Vaccination Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Meningococcal Vaccination Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Meningococcal Vaccination Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Polysaccharide
Figure 10. Product Picture of Conjugate
Figure 11. Product Picture of Combination
Figure 12. Global Meningococcal Vaccination Sales Market Share by Type in 2022
Figure 13. Global Meningococcal Vaccination Revenue Market Share by Type (2018-2023)
Figure 14. Meningococcal Vaccination Consumed in Pneumonia
Figure 15. Global Meningococcal Vaccination Market: Pneumonia (2018-2023) & (K Units)
Figure 16. Meningococcal Vaccination Consumed in Meningitis
Figure 17. Global Meningococcal Vaccination Market: Meningitis (2018-2023) & (K Units)
Figure 18. Meningococcal Vaccination Consumed in Bacteremia
Figure 19. Global Meningococcal Vaccination Market: Bacteremia (2018-2023) & (K Units)
Figure 20. Meningococcal Vaccination Consumed in Others
Figure 21. Global Meningococcal Vaccination Market: Others (2018-2023) & (K Units)
Figure 22. Global Meningococcal Vaccination Sales Market Share by Application (2022)
Figure 23. Global Meningococcal Vaccination Revenue Market Share by Application in 2022
Figure 24. Meningococcal Vaccination Sales Market by Company in 2022 (K Units)
Figure 25. Global Meningococcal Vaccination Sales Market Share by Company in 2022
Figure 26. Meningococcal Vaccination Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Meningococcal Vaccination Revenue Market Share by Company in 2022
Figure 28. Global Meningococcal Vaccination Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Meningococcal Vaccination Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Meningococcal Vaccination Sales 2018-2023 (K Units)
Figure 31. Americas Meningococcal Vaccination Revenue 2018-2023 ($ Millions)
Figure 32. APAC Meningococcal Vaccination Sales 2018-2023 (K Units)
Figure 33. APAC Meningococcal Vaccination Revenue 2018-2023 ($ Millions)
Figure 34. Europe Meningococcal Vaccination Sales 2018-2023 (K Units)
Figure 35. Europe Meningococcal Vaccination Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Meningococcal Vaccination Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Meningococcal Vaccination Revenue 2018-2023 ($ Millions)
Figure 38. Americas Meningococcal Vaccination Sales Market Share by Country in 2022
Figure 39. Americas Meningococcal Vaccination Revenue Market Share by Country in 2022
Figure 40. Americas Meningococcal Vaccination Sales Market Share by Type (2018-2023)
Figure 41. Americas Meningococcal Vaccination Sales Market Share by Application (2018-2023)
Figure 42. United States Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Meningococcal Vaccination Sales Market Share by Region in 2022
Figure 47. APAC Meningococcal Vaccination Revenue Market Share by Regions in 2022
Figure 48. APAC Meningococcal Vaccination Sales Market Share by Type (2018-2023)
Figure 49. APAC Meningococcal Vaccination Sales Market Share by Application (2018-2023)
Figure 50. China Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Meningococcal Vaccination Sales Market Share by Country in 2022
Figure 58. Europe Meningococcal Vaccination Revenue Market Share by Country in 2022
Figure 59. Europe Meningococcal Vaccination Sales Market Share by Type (2018-2023)
Figure 60. Europe Meningococcal Vaccination Sales Market Share by Application (2018-2023)
Figure 61. Germany Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Meningococcal Vaccination Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Meningococcal Vaccination Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Meningococcal Vaccination Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Meningococcal Vaccination Sales Market Share by Application (2018-2023)
Figure 70. Egypt Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Meningococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Meningococcal Vaccination in 2022
Figure 76. Manufacturing Process Analysis of Meningococcal Vaccination
Figure 77. Industry Chain Structure of Meningococcal Vaccination
Figure 78. Channels of Distribution
Figure 79. Global Meningococcal Vaccination Sales Market Forecast by Region (2024-2029)
Figure 80. Global Meningococcal Vaccination Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Meningococcal Vaccination Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Meningococcal Vaccination Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Meningococcal Vaccination Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Meningococcal Vaccination Revenue Market Share Forecast by Application (2024-2029)